Clay B. Siegall
2021
Compensation breakdown
Non-Equity Incentive Plan | $1,835,467 |
---|---|
Option Awards | $4,831,830 |
Salary | $1,133,969 |
Stock Awards | $10,985,182 |
Other | $119,996 |
Total | $18,906,444 |
Siegall received $11M in stock awards, accounting for 58% of the total pay in 2021.
Siegall also received $1.8M in non-equity incentive plan, $4.8M in option awards, $1.1M in salary and $120K in other compensation.
Rankings
In 2021, Clay B. Siegall's compensation ranked 362nd out of 12,415 executives tracked by ExecPay. In other words, Siegall earned more than 97.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 362 | 97th |
Manufacturing | 109 | 98th |
Chemicals And Allied Products | 34 | 99th |
Drugs | 30 | 99th |
Biological Products, Except Diagnostic Substances | 14 | 97th |
Pay ratio
Clay B. Siegall's Pay | $18,906,444 |
---|---|
Median Employee's Pay | $250,158 |
Pay Ratio | 76to 1 |
In 2021, the annual total compensation of Clay B. Siegall was $18,906,444.
The annual total compensation of the median employee at Seattle Genetics was $250,158.
The ratio of Clay B. Siegall's pay to the pay of median employee was therefore 76 to one.
Siegall's colleagues
We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2021.